These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-003735-31 Randomizált, kettős vak, multicentrikus vizsgálat disztális, szenzomotoros típusú diabéteszes neuropátiás fájdalomban az együttesen adott emelkedő dózisú 150 mg-os tolperisone filmtabletta és 30 mg-os... not-yet-due
Ongoing 2005-001201-25 Phase II placebo-controlled study to evaluate the efficacy, safety and tolerability of RGH-896 in patients with pain due to diabetic sensorimotor peripheral neuropathy not-yet-due
Completed, but no date 2005-002780-82 Alendronat (Sedron 70 mg) hatékonyságának és biztonságosságának nyílt, multicentrikus, fázis IV vizsgálata osteoporosisban szenvedő veseköves férfibetegekben bad-data
Not reported 2005-004339-23 Cink-hyaluronát (Curiosin®) gél és adapalen (Differin®) gél kezelés hatása az életminőség alakulására és a két gyógyszerkészítmény összehasonlító tolerabilitási vizsgálata acnes betegeken. 2006-06-06 due-trials
Not reported 2005-005749-20 Amlodipint és lisinoprilt tartalmazó fix gyógyszerkombináció (Lisonorm®) hatásosságának és biztonságosságának vizsgálata essentialis hypertoniás betegeken (ALFESS) 2007-08-28 due-trials
Reported results 2006-004641-42 Single center, exploratoric, open-label study to investigate the precise mechanism of action of Cavinton (vinpocetin) 2011-04-07 due-trials
Reported results 2006-005841-13 Multicenter, open-label study to investigate the efficacy and safety of Cavinton Forte (vinpocetine) tablet in patients with mild cognitive impairment (MCI). 2009-12-30 due-trials
Completed, but no date, and reported results 2008-001835-36 Single center, exploratoric, open-label study to investigate the add-on effect of vinpocetin to the haemorheological effect of 100 mg acetyl-salicylicum in patients with chronic cerebrovascular diseas... bad-data
Reported results 2008-005032-33 Single center, exploratoric, double-blind, placebo controlled study to investigate the efficacy and tolerability of vinpocetine in patients with non-proliferative diabetic retinopathy 2011-08-31 due-trials
Completed, but no date, and reported results 2009-013864-37 A randomized, multicenter, double-blind, parallel study to compare the efficacy and safety profile of RGH-507 (tolperisone-containing) gel versus a ketoprofen-containing gel in the treatment of patien... bad-data
Not reported 2011-000931-10 An Exploratory, Double-Blind, Randomized, Placebo and Active-Controlled Study to Assess the Safety and Efficacy of RGH-478 for the Treatment of Moderate to Severe Pain in Osteoarthritis of the Knee 2012-08-08 due-trials
Not reported 2012-005485-36 A kariprazin hatásosságának, biztonságosságának és tolerálhatóságának randomizált, kettős vak, párhuzamos csoportos vizsgálata túlnyomórészt negatív tünetes skizofrén betegeknél 2014-11-17 due-trials
Not reported 2013-003166-14 Multiple, fixed-dose, comparative efficacy and safety evaluation of RGB-02 and Neulasta® in patients undergoing chemotherapy treatment known to induce neutropenia. 2015-04-08 due-trials
Completed, but no date Terminated 2013-003303-18 Clinical phase IV study assessing the efficacy and safety of the medicinal product Groprinosin in treatment of recurrent airway inflammation in children with impaired cellular immunity and diagnosed o... bad-data
Exempt 2014-003255-54 A Double-blind, Randomised, Comparative Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Evaluation of RGB-03 and MabThera® Combined with Methotrexate in Rheumatoid Arthritis Patients 2018-04-24 not-yet-due
Completed, report not yet due 2016-002327-29 Open-Label, Multicentre, Multiple Dose Study to Evaluate Pharmacokinetics, Safety and Tolerability of Cariprazine in Adolescent Subjects with Schizophrenia, Schizoaffective- and Schizophreniform Disor... 2018-06-19 not-yet-due